TP53 and cancer: Among the 5 deceased patients, 4 patients died due to MB progression (including 1 with the somatic TP53 PV) (median time since diagnosis: 1.7 years, range [0.8–2.1]) and 1 because of secondary cancer arising in the irradiation field (malignant high-grade glioma).